DK0781279T3 - Quinoxalindion-NMDA-receptorantagonister - Google Patents
Quinoxalindion-NMDA-receptorantagonisterInfo
- Publication number
- DK0781279T3 DK0781279T3 DK95931989T DK95931989T DK0781279T3 DK 0781279 T3 DK0781279 T3 DK 0781279T3 DK 95931989 T DK95931989 T DK 95931989T DK 95931989 T DK95931989 T DK 95931989T DK 0781279 T3 DK0781279 T3 DK 0781279T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- alkyl
- group
- date mar
- ch2ch3
- Prior art date
Links
- 229940127523 NMDA Receptor Antagonists Drugs 0.000 title 1
- SEPKUNXLGWMPHL-UHFFFAOYSA-N quinoxaline-2,3-dione Chemical compound C1=CC=CC2=NC(=O)C(=O)N=C21 SEPKUNXLGWMPHL-UHFFFAOYSA-N 0.000 title 1
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 abstract 4
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 3
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 abstract 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 abstract 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
- 125000002373 5 membered heterocyclic group Chemical group 0.000 abstract 1
- 206010019196 Head injury Diseases 0.000 abstract 1
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 206010039966 Senile dementia Diseases 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 125000002785 azepinyl group Chemical group 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000000472 traumatic effect Effects 0.000 abstract 1
- 125000001425 triazolyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9418443A GB9418443D0 (en) | 1994-09-13 | 1994-09-13 | Therapeutic agents |
| PCT/EP1995/003483 WO1996008485A1 (fr) | 1994-09-13 | 1995-09-01 | Antagonistes du recepteur nmda, a base de quinoxalinedione |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0781279T3 true DK0781279T3 (da) | 2001-09-03 |
Family
ID=10761258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95931989T DK0781279T3 (da) | 1994-09-13 | 1995-09-01 | Quinoxalindion-NMDA-receptorantagonister |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5783572A (fr) |
| EP (1) | EP0781279B1 (fr) |
| JP (1) | JP2898097B2 (fr) |
| AT (1) | ATE202099T1 (fr) |
| CA (1) | CA2199845C (fr) |
| DE (1) | DE69521323T2 (fr) |
| DK (1) | DK0781279T3 (fr) |
| ES (1) | ES2158126T3 (fr) |
| FI (1) | FI113471B (fr) |
| GB (1) | GB9418443D0 (fr) |
| GR (1) | GR3036270T3 (fr) |
| MX (1) | MX9701894A (fr) |
| PT (1) | PT781279E (fr) |
| WO (1) | WO1996008485A1 (fr) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5874426A (en) * | 1995-06-07 | 1999-02-23 | Warner-Lambert Company | Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| US6110911A (en) * | 1995-06-07 | 2000-08-29 | Warner-Lambert Company | Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| MY132385A (en) * | 1995-08-31 | 2007-10-31 | Novartis Ag | 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives |
| GB9605027D0 (en) | 1996-03-09 | 1996-05-08 | Pfizer Ltd | Quinoxalinediones |
| AU5367598A (en) * | 1996-11-25 | 1998-06-22 | Warner-Lambert Company | Urea and thiourea derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| US6172065B1 (en) | 1997-03-04 | 2001-01-09 | Warner-Lambert Company | Urea and thiourea derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| US6340758B1 (en) * | 1997-05-16 | 2002-01-22 | Warner-Lambert Company | Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agents |
| TW403740B (en) | 1997-06-10 | 2000-09-01 | Novartis Ag | Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide |
| DE19936521A1 (de) * | 1999-08-06 | 2001-02-15 | Gruenenthal Gmbh | Substituierte Pyrrolidin-2,3,4-trion-3-oxim-Derivate |
| AU2002250256B2 (en) * | 2001-03-08 | 2008-04-03 | Emory University | pH-dependent NMDA receptor antagonists |
| US7732162B2 (en) | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
| WO2006071274A2 (fr) * | 2004-12-23 | 2006-07-06 | Voyager Pharmaceutical Corporation | Acetate de leuprolide et inhibiteurs de l'acetylcholinesterase ou antagonistes des recepteurs nmda pour le traitement de la maladie d'alzheimer |
| EP2089383B1 (fr) | 2006-11-09 | 2015-09-16 | Probiodrug AG | Dérivés 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one utiles en tant qu' inhibiteurs de la glutaminyl-cyclase dans le traitement des ulcères, du cancer et d'autres maladies |
| DK2091948T3 (da) | 2006-11-30 | 2012-07-23 | Probiodrug Ag | Nye inhibitorer af glutaminylcyclase |
| CA2679446C (fr) | 2007-03-01 | 2016-05-17 | Probiodrug Ag | Nouvelle utilisation d'inhibiteurs de la glutaminyl cyclase |
| US9656991B2 (en) | 2007-04-18 | 2017-05-23 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| MX2009014216A (es) * | 2007-06-29 | 2010-07-05 | Univ Emory | Antagonistas del receptor nmda para neuroproteccion. |
| MX2012002993A (es) | 2009-09-11 | 2012-04-19 | Probiodrug Ag | Derivados heterociclicos como inhibidores de ciclasa glutaminilo. |
| WO2011107530A2 (fr) | 2010-03-03 | 2011-09-09 | Probiodrug Ag | Nouveaux inhibiteurs |
| JP5688745B2 (ja) | 2010-03-10 | 2015-03-25 | プロビオドルグ エージー | グルタミニルシクラーゼ（ｑｃ、ｅｃ２．３．２．５）の複素環阻害剤 |
| EP2560953B1 (fr) | 2010-04-21 | 2016-01-06 | Probiodrug AG | Inhibiteurs de glutaminyl cyclase |
| BR112013014484A2 (pt) * | 2010-12-13 | 2016-07-19 | Viamet Pharmaceuticals Inc | compostos inibidores de metaloenzimas |
| ES2570167T3 (es) | 2011-03-16 | 2016-05-17 | Probiodrug Ag | Derivados de benzimidazol como inhibidores de glutaminil ciclasa |
| DE102015011861B4 (de) | 2015-09-10 | 2018-03-01 | Rudolf Schindler | Neue cyclische Carboxamide als NMDA NR2B Rezeptor Inhibitoren |
| ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ221729A (en) * | 1986-09-15 | 1989-07-27 | Janssen Pharmaceutica Nv | Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions |
| GB8827822D0 (en) * | 1988-11-29 | 1988-12-29 | Janssen Pharmaceutica Nv | (1h-azol-1-ylmethyl)substituted quinoline derivatives |
| DK715888D0 (da) * | 1988-12-22 | 1988-12-22 | Ferrosan As | Quinoxalinforbindelser, deres fremstilling og anvendelse |
| DE4217952A1 (de) * | 1992-05-30 | 1993-12-02 | Basf Ag | Chinoxalin-2,3(1H,4H)-dione |
| DE69334237D1 (de) * | 1992-06-22 | 2008-09-25 | State Of Oregon Through Oregon | Glycinrezeptorantagonisten und ihre verwendung |
-
1994
- 1994-09-13 GB GB9418443A patent/GB9418443D0/en active Pending
-
1995
- 1995-09-01 US US08/793,896 patent/US5783572A/en not_active Expired - Fee Related
- 1995-09-01 PT PT95931989T patent/PT781279E/pt unknown
- 1995-09-01 CA CA002199845A patent/CA2199845C/fr not_active Expired - Fee Related
- 1995-09-01 DE DE69521323T patent/DE69521323T2/de not_active Expired - Fee Related
- 1995-09-01 AT AT95931989T patent/ATE202099T1/de not_active IP Right Cessation
- 1995-09-01 JP JP8509872A patent/JP2898097B2/ja not_active Expired - Fee Related
- 1995-09-01 EP EP95931989A patent/EP0781279B1/fr not_active Expired - Lifetime
- 1995-09-01 MX MX9701894A patent/MX9701894A/es not_active IP Right Cessation
- 1995-09-01 WO PCT/EP1995/003483 patent/WO1996008485A1/fr active IP Right Grant
- 1995-09-01 ES ES95931989T patent/ES2158126T3/es not_active Expired - Lifetime
- 1995-09-01 DK DK95931989T patent/DK0781279T3/da active
-
1997
- 1997-03-12 FI FI971026A patent/FI113471B/fi active
-
2001
- 2001-07-24 GR GR20010401119T patent/GR3036270T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2898097B2 (ja) | 1999-05-31 |
| PT781279E (pt) | 2001-09-28 |
| GR3036270T3 (en) | 2001-10-31 |
| JPH09511523A (ja) | 1997-11-18 |
| CA2199845C (fr) | 2000-08-01 |
| FI971026A0 (fi) | 1997-03-12 |
| FI971026A (fi) | 1997-03-12 |
| WO1996008485A1 (fr) | 1996-03-21 |
| FI113471B (fi) | 2004-04-30 |
| ATE202099T1 (de) | 2001-06-15 |
| CA2199845A1 (fr) | 1996-03-21 |
| MX9701894A (es) | 1997-06-28 |
| DE69521323D1 (de) | 2001-07-19 |
| EP0781279B1 (fr) | 2001-06-13 |
| GB9418443D0 (en) | 1994-11-02 |
| DE69521323T2 (de) | 2001-09-20 |
| US5783572A (en) | 1998-07-21 |
| EP0781279A1 (fr) | 1997-07-02 |
| ES2158126T3 (es) | 2001-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0781279T3 (da) | Quinoxalindion-NMDA-receptorantagonister | |
| IL103657A0 (en) | Acyclic ethylenediamine derivatives | |
| FI962753A (fi) | Menetelmä lääkeaineena käytt¦kelpoisen piperidyyli- tai pyrrolidiinijohdannaisen tai sen farmaseuttisen suolan valmistamiseksi | |
| DE69409525D1 (de) | Acetamidderivate und ihre verwendung als modifizierungsmittel des verhaltens der verdauung | |
| DE69225500D1 (de) | Chinazolinone als mittel gegen angina | |
| NZ508910A (en) | Di-substituted piperazine or piperidine derivatives useful as muscarinic antagonists | |
| PT100620A (pt) | Derivados de tetra-hidrocarbazol, seu uso e preparacao e composicoes farmaceuticas que os contem | |
| DE69528485T2 (de) | Biphenylderivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel | |
| DE69402981D1 (de) | 3,5-dioxo-(2h,4h)-1,2,4-triazine als 5ht1a ligande | |
| NZ331060A (en) | Quinoxalinediones, preparation and pharmaceutical compositions thereof | |
| ATE147071T1 (de) | 1,4-disubstituierte piperidinderivate, ihre herstellung und therapeutische verwendung | |
| NZ331613A (en) | Piperazinyl or piperidinyl substituted 1,2,3,4-tetrahydronaphthalene derivatives | |
| DK0510003T3 (da) | Piperidin-og pyrrolidinderivater | |
| ATE214056T1 (de) | Benzodiazepinderivate | |
| DK0553278T3 (da) | 2-Phenyl- og 2-thienyl-(2)-piperidinderivater med neurobeskyttende egenskaber | |
| DK0461012T3 (da) | Derivater af ((1-arylpyrrolidin-2-yl)methyl)piperazin, fremstillingen heraf og deres terapeutiske anvendelse |